SiNtx Technologies (SINT) Stock: Buy, Sell, or Hold?
SINT - SiNtx Technologies, Inc. Common Stock
$2.21
0.08 (3.76%)
▲
5d:
+17.55%
30d:
+45.39%
90d:
+18.18%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When SINT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SINT is 14.5% above its trading range ($1.93). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SINT is 14.5% above its trading range ($1.93). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SINT is currently trading at $2.21, which is considered extended relative to its 30-day fair value range of $1.55 to $1.93.
Technical Outlook: Technically, SINT is in a downtrend. Immediate support is located at $1.69, while resistance sits at $2.39. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SINT scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.25 (+318.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SINT is in a downtrend. Immediate support is located at $1.69, while resistance sits at $2.39. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SINT scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.25 (+318.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.55 -
$1.93
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+14.5% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 318.6% below Wall St target ($9.25)
- WARNING: Composite score 28/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.55 -
$1.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$2.39
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.08
Wall Street Target
$9.25
(+318.6%)
Revenue Growth (YoY)
199.3%
Share & Embed Analysis
Last updated: October 04, 2026 12:10 AM ET
Data refreshes hourly during market hours. Next update: 1:10 AM
Data refreshes hourly during market hours. Next update: 1:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SINT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
